XML 21 R6.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Accumulated Deficit [Member]
AOCI Attributable to Parent [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Beginning Balance at Dec. 31, 2013 $ 284,661 $ (539,597) $ 0 $ 2,155 $ 822,103 $ 0
Beginning Balance (in shares) at Dec. 31, 2013       21,553   4
Net loss (5,149) (5,149)        
Stock options exercised, net 1,289     $ 2 (2,716) $ 4,003
Stock options exercised, net (in shares)       18   198
Issuance of restricted stock, net 98       (1,594) $ 1,692
Issuance of restricted stock, net (in shares)           (79)
Stock-based compensation expense 1,935       1,935  
Repurchase of common stock (25,036)         $ (25,036)
Repurchase of common stock (in shares)           1,194
Other comprehensive loss 29       29  
Conversion of convertible senior debentures to common stock (in shares)       2    
Share of other comprehensive loss of equity method investments 0          
Ending Balance at Dec. 31, 2014 257,827 (544,746) 0 $ 2,157 819,757 $ (19,341)
Ending Balance (in shares) at Dec. 31, 2014       21,573   921
Net loss (59,524) (59,524)        
Stock options exercised, net 676       (1,051) $ 1,727
Stock options exercised, net (in shares)           83
Issuance of restricted stock, net 158       (2,883) $ 3,041
Issuance of restricted stock, net (in shares)           149
Stock-based compensation expense 1,611       1,611  
Repurchase of common stock (4,997)         $ (4,997)
Repurchase of common stock (in shares)           304
Share of other comprehensive loss of equity method investments (246)   (246)      
Ending Balance at Dec. 31, 2015 195,505 (604,270) (246) $ 2,157 817,434 $ (19,570)
Ending Balance (in shares) at Dec. 31, 2015       21,573   993
Net loss (22,262) (22,262)        
Stock options exercised, net (318)       (1,117) $ 799
Stock options exercised, net (in shares)           46
Issuance of restricted stock, net 32       (3,067) $ 3,099
Issuance of restricted stock, net (in shares)           162
Stock-based compensation expense 2,394       2,394  
Repurchase of common stock (5,389)         $ (5,389)
Repurchase of common stock (in shares)           424
Share of other comprehensive loss of equity method investments (185)   (185)      
Ending Balance at Dec. 31, 2016 $ 169,777 $ (626,904) $ (431) $ 2,157 $ 816,016 $ (21,061)
Ending Balance (in shares) at Dec. 31, 2016       21,573   1,209